NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 84 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,000 | -75.6% | 15,741 | -60.4% | 0.00% | – |
| Q2 2022 | $41,000 | -67.5% | 39,759 | -40.5% | 0.00% | – |
| Q1 2022 | $126,000 | -43.2% | 66,772 | +45.5% | 0.00% | – |
| Q4 2021 | $222,000 | -73.9% | 45,897 | -61.0% | 0.00% | – |
| Q3 2021 | $850,000 | -55.9% | 117,656 | -43.6% | 0.00% | – |
| Q2 2021 | $1,927,000 | -53.8% | 208,717 | -38.3% | 0.00% | -100.0% |
| Q1 2021 | $4,167,000 | +941.8% | 338,530 | +1091.0% | 0.00% | – |
| Q4 2020 | $400,000 | +205.3% | 28,423 | +160.9% | 0.00% | – |
| Q3 2020 | $131,000 | -89.3% | 10,893 | -89.9% | 0.00% | – |
| Q1 2020 | $1,224,000 | +547.6% | 107,522 | +602.6% | 0.00% | – |
| Q4 2019 | $189,000 | – | 15,304 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,386,300 | $19,547,000 | 2.55% |
| EcoR1 Capital, LLC | 3,122,704 | $44,030,000 | 2.37% |
| Redmile Group, LLC | 4,131,869 | $58,259,000 | 0.70% |
| Boxer Capital, LLC | 1,501,058 | $21,165,000 | 0.68% |
| HighVista Strategies LLC | 69,727 | $983,000 | 0.63% |
| Baker Brothers Advisors | 3,821,740 | $53,887,000 | 0.20% |
| Highland Private Wealth Management | 93,998 | $1,326,000 | 0.12% |
| Sio Capital Management, LLC | 38,312 | $540,000 | 0.11% |
| Point72 Asset Management, L.P. | 1,195,725 | $16,860,000 | 0.08% |
| Granahan Investment Management | 246,299 | $3,473,000 | 0.08% |